Australian Clinical Labs
ACL.AX
#6838
Rank
A$0.70 B
Marketcap
$3.50
Share price
0.00%
Change (1 day)
34.70%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: $0.18

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is $0.18. In 2023 the company made an earnings per share (EPS) of $0.18 a decrease over its 2022 EPS that were of $0.93.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023$0.18-80.55%
2022$0.93104.3%
2021$0.46